These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2561924)

  • 1. [Comparison of the susceptibility of Candida strains to ketoconazole and itraconazole in in vitro experiments].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(5-6):399-404. PubMed ID: 2561924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro investigations of Candida strains for itraconazole].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(1):23-7. PubMed ID: 2554367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Alvarado D; Díaz MC; Silva V
    Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The sensitivity to ketoconazole of Candida strains isolated from the digestive tract ontocenoses in children].
    Horwatt-Bozyczko E; Kurnatowski M; Wasowska-Królikowska K; Kurnatowska A
    Wiad Parazytol; 2001; 47(4):929-33. PubMed ID: 16886449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):572-4. PubMed ID: 2166936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro effect of itraconazole against various species of Candida].
    Bastide M; Mallie M; Jouvert S; Montes B; Bastide JM
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):694-9. PubMed ID: 2552381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of ketoconazole on the activity of asparagine protease produced by Candida strains.
    Kurnatowski P; Grabek A
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():265-76. PubMed ID: 17564323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
    Arzeni D; Barchiesi F; Ancarani F; Scalise G
    J Chemother; 1991 Jun; 3(3):139-42. PubMed ID: 1655990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-Candida activity of azoles].
    Van Cutsem J; Van Gerven F; Janssen PA
    Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
    Nawrot U; Nowicka J; Juszczak K; Gusin B
    Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans.
    St-Germain G
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2304-6. PubMed ID: 1965104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole activity against fungal germination.
    Strippoli V; Simonetti N; Retico A; Lucchetti G
    Drugs Exp Clin Res; 1988; 14(5):341-5. PubMed ID: 2851427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.